Skip to main content

Table 1 Antimicrobial resistance of subsequent infecting carbapenem-resistant Enterobacterale isolates

From: Prevalence and factors associated with carbapenem-resistant Enterobacterales (CRE) infection among hematological malignancies patients with CRE intestinal colonization

Antimicrobial agents

Number of isolates (%)

Resistance

Susceptibility

Meropenem

18 (100)

0 (0)

Imipenem

18 (100)

0 (0)

Ertapenem

18 (100)

0 (0)

Ampicillin-sulbactam

18 (100)

0 (0)

Piperacillin-tazobactam

18 (100)

0 (0)

Cefazolin

18 (100)

0 (0)

Cefuroxime

18 (100)

0 (0)

Ceftriaxone

18 (100)

0 (0)

Ceftazidime

18 (100)

0 (0)

Cefepime

18 (100)

0 (0)

Cefotetan

18 (100)

0 (0)

Aztreonam

18 (100)

0 (0)

Ciprofloxacin

18 (100)

0 (0)

Levofloxacin

18 (100)

0 (0)

Gentamicin

18 (100)

0 (0)

Tobramycin

18 (100)

0 (0)

Amikacin

16 (88.9)

2 (11.1)

Trimethoprim-sulfamethoxazole

18 (100)

0 (0)

Tigecyclin

16 (88.9)

2 (11.1)

Colistin

1 (5.6)

17 (94.4)